Rocket Lab Slides 6% on Mars Mission Funding Cut and Sector Selling
Rocket Lab shares slid 6% Thursday after Congress cut funding for its 2031 Mars sample-return mission and AST SpaceMobile’s $1 billion convertible note deal sparked sectorwide selling. Volatility also stems from a Neutron rocket stage-1 tank rupture during recent qualification tests, fueling concerns over potential launch delays.
1. Stock Performance and Sector Pressure
Rocket Lab shares declined 6% on Thursday, adding to a 27% drop this month as space-related equities faced heavy selling. A major convertible note offering by a peer spurred sectorwide de-risking, exacerbating volatility for capital-intensive launch providers like Rocket Lab.
2. Government Funding Cut for Mars Mission
Congress decided to withhold funding for Rocket Lab’s proposed 2031 Mars sample-return mission, prompting investors to reassess the company’s long-term revenue potential and margin projections. The funding cut removes a key government-backed contract that had underpinned future growth hopes.
3. Neutron Rocket Development and Test Setbacks
Rocket Lab continues to build its medium-lift Neutron rocket with a reported backlog exceeding $1 billion. However, a stage-1 tank rupture during recent qualification tests has raised concerns about potential schedule delays for the first launch of its reusable vehicle.